Medication-Assisted Treatment in Oregon's Correctional System

Medication-assisted treatment, often called MAT or more precisely medication for opioid use disorder (MOUD), has become a major part of the conversation about jail and prison health care in the United States. In Oregon, the topic is especially important because the state has publicly emphasized treatment, recovery, and overdose prevention as part of its broader response to substance use disorder. Oregon Health Authority describes MAT/MOUD as a medically monitored approach that combines medication with counseling, case management, and other supports. That framework matters in correctional settings, where many people enter custody with untreated opioid use disorder or lose access to care during incarceration. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

In practical terms, MAT in jails and prisons can include methadone, buprenorphine, and extended-release naltrexone, depending on the clinical situation and the facility's capacity. Oregon's current public materials and funding plans show that the state is not treating this as a side issue. Instead, it is building a system that supports treatment inside custody and, importantly, continuity of care after release. That continuity is one of the strongest reasons correctional MAT has gained attention nationwide. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

Why MAT Matters Behind Bars

People in jail and prison often have higher rates of substance use disorder than the general population, and opioid use disorder can be especially dangerous because withdrawal, relapse, and overdose risk can all rise during and after incarceration. Oregon's own opioid settlement implementation materials state that MOUD in jail settings is effective at increasing post-release community treatment, reducing post-release illicit opioid use, and lowering the odds of post-release overdose. Those are not small benefits; they go directly to public health, safety, and reentry success. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

Correctional health care also has a legal and operational dimension. Oregon DOC says adults in custody are entitled to health care during incarceration, and the department provides medical, behavioral health, and pharmacy services through its Health Services system. That means substance use treatment is not just a policy preference; it sits within a broader obligation to provide medically necessary care. ([oregon.gov](https://www.oregon.gov/doc/divisions-and-units/Pages/Health-Services.aspx))

How Oregon Is Approaching MAT in Jails and Prisons

Oregon's approach appears to be a mix of state-level policy, correctional health services, and local jail implementation. The Oregon Department of Corrections provides ongoing medical and behavioral health services to adults in custody, and its policies include treatment programs and naloxone-related guidance. DOC also uses a managed-care style health model, which can help standardize care across facilities. ([oregon.gov](https://www.oregon.gov/doc/inmate-services/pages/health-and-wellness.aspx))

At the state level, Oregon Health Authority continues to frame MAT/MOUD as a core treatment option for opioid use disorder. OHA's public pages emphasize that MAT is medically monitored and includes counseling and medication management, while also pointing people to Oregon-approved opioid treatment programs. That public health infrastructure matters because correctional facilities often need outside partners for dosing, referrals, and post-release linkage. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

Oregon is also using settlement and grant funding to expand jail-based MOUD. A state implementation document for opioid settlement funds says the purpose is to help local jails establish or improve MOUD services, including methadone, buprenorphine formulations, and extended-release naltrexone. The same document notes that Oregon is preparing jails to take advantage of the Criminal Justice Commission's Jail MOUD grant program and a Medicaid 1115 waiver demonstration for carceral settings. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

What This Looks Like in Local Jails

Local jails are often where the biggest implementation challenges show up, because county facilities vary widely in size, staffing, medical capacity, and access to outside providers. Oregon's Criminal Justice Commission materials show that multiple county jail programs are already seeking or receiving support for MAT-related services. Examples listed in the commission packet include Lane County Jail, Lincoln County Jail, Malheur County Jail, Marion County Jail, and Northern Oregon Regional Corrections, each with different service models and staffing needs. ([oregon.gov](https://www.oregon.gov/cjc/CJC%20Document%20Library/2025.11%20Commission%20Meeting%20Packet.pdf))

That variation is important. Some jails may rely on in-house medical teams, while others contract with community providers or telemedicine partners. Some may focus on screening and assessment, while others aim to maintain medication during custody and continue treatment after release. Oregon's funding approach suggests the state understands that one model will not fit every jail. ([oregon.gov](https://www.oregon.gov/cjc/CJC%20Document%20Library/2025.11%20Commission%20Meeting%20Packet.pdf))

Why Continuity of Care Is the Key Issue

The most effective correctional MAT programs do more than start medication inside the facility. They also connect people to care when they leave. Oregon's settlement implementation plan specifically highlights post-release treatment linkage as a goal. That is critical because the period right after release is high risk, especially for overdose. Oregon's own materials note that the risk of death from synthetic opioid overdose is dramatically elevated in the first two weeks after incarceration. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

In a state like Oregon, continuity can mean coordination between jails, the Department of Corrections, community treatment providers, Medicaid systems, and peer support services. Oregon Health Authority also points to peer-delivered services and recovery supports as part of the broader behavioral health landscape, which can help people stay engaged after release. ([oregon.gov](https://www.oregon.gov/oha/bh/adults/pages/substance-use.aspx))

Challenges Oregon Still Faces

Even with strong policy support, MAT in jails and prisons is not simple. Facilities need trained staff, secure medication storage, clinical protocols, and referral pathways. They also need to manage stigma, because some people still misunderstand MAT as replacing one drug with another rather than treating a chronic medical condition. Oregon's public health pages repeatedly frame MAT as medically monitored treatment, which is an important counterpoint to that stigma. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

Another challenge is consistency. A person may receive medication in one jail, but if the next facility does not offer the same service, treatment can be interrupted. Oregon's current funding and technical assistance efforts appear designed to reduce that patchwork effect, but implementation across all counties will likely take time. ([oregon.gov](https://www.oregon.gov/cjc/CJC%20Document%20Library/2025.11%20Commission%20Meeting%20Packet.pdf))

What to Watch Next in Oregon

As of today, Oregon appears to be moving toward broader access to MOUD in correctional settings, with state agencies, county jails, and funding programs all pointing in the same direction. The most important developments to watch are whether more jails adopt medication programs, whether release planning improves, and whether Oregon can maintain treatment access across the jail-to-community transition. ([oregon.gov](https://www.oregon.gov/cjc/CJC%20Document%20Library/2025.11%20Commission%20Meeting%20Packet.pdf))

For readers following jail health policy, Oregon is a state worth watching because it combines public health language, correctional health obligations, and active funding support. The result is a practical model that treats opioid use disorder as a medical condition that can and should be addressed during incarceration, not only after release. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

Bottom Line

Medication-assisted treatment in Oregon jails and prisons is no longer a fringe idea. It is part of a broader state strategy to reduce overdose, improve reentry outcomes, and connect people to ongoing care. While implementation still varies by facility and county, Oregon's current public materials show clear momentum toward expanding MOUD in correctional settings. For people in custody, families, providers, and policymakers, that is a meaningful shift with real public health consequences. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))

• MAT/MOUD is recognized in Oregon as a medically monitored treatment for opioid use disorder. ([oregon.gov](https://www.oregon.gov/oha/hsd/amh/pages/mat.aspx))
• Oregon DOC provides health services, including behavioral health and pharmacy care, to adults in custody. ([oregon.gov](https://www.oregon.gov/doc/inmate-services/pages/health-and-wellness.aspx))
• Oregon is funding and supporting jail-based MOUD expansion through settlement funds and grant programs. ([oregon.gov](https://www.oregon.gov/cjc/CJC%20Document%20Library/2025.11%20Commission%20Meeting%20Packet.pdf))
• Continuity of care after release is a central goal because overdose risk rises sharply after incarceration. ([oregon.gov](https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SUBSTANCEUSE/OPIOIDS/Documents/OHA%20implementation%20plan%20for%20allocation%20of%20opioid%20settlement%20funds.pdf))

Other Relevant Articles for Oregon

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate